Companies Combine to Form Ion Channel Consortium
Complete the form below to unlock access to ALL audio articles.
Together, the three companies will offer value added identification and validation of ion channel modulators. The Ion Channel Consortium combines Alion’s proprietary method for short-listing drug candidates, Specs’ reliable sourcing and synthesis of compounds, and Aurora’s patch clamp services.
Researchers now have an option that enables time and cost savings while providing a unique method to identify new drug candidates for channelopathies.